Capital Asset Pricing Model (CAPM)
Capital asset pricing model (CAPM) indicates what should be the expected or required rate of return on risky assets like Celgene Corp. common stock.
Paying user area
Try for free
Celgene Corp. pages available for free this week:
- Common-Size Income Statement
- Analysis of Profitability Ratios
- Analysis of Long-term (Investment) Activity Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Enterprise Value to FCFF (EV/FCFF)
- Net Profit Margin since 2005
- Return on Assets (ROA) since 2005
- Total Asset Turnover since 2005
- Price to Operating Profit (P/OP) since 2005
- Analysis of Revenues
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Celgene Corp. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Rates of Return
Celgene Corp., monthly rates of return
| Celgene Corp. (CELG) | Standard & Poor’s 500 (S&P 500) | |||||
|---|---|---|---|---|---|---|
| t | Date | PriceCELG,t1 | DividendCELG,t1 | RCELG,t2 | PriceS&P 500,t | RS&P 500,t3 |
| Jan 31, 2014 | ||||||
| 1. | Feb 28, 2014 | |||||
| 2. | Mar 31, 2014 | |||||
| 3. | Apr 30, 2014 | |||||
| . | . | . | . | . | . | . |
| . | . | . | . | . | . | . |
| . | . | . | . | . | . | . |
| 58. | Nov 30, 2018 | |||||
| 59. | Dec 31, 2018 | |||||
| Average (R): | ||||||
| Standard deviation: | ||||||
| Celgene Corp. (CELG) | Standard & Poor’s 500 (S&P 500) | |||||
|---|---|---|---|---|---|---|
| t | Date | PriceCELG,t1 | DividendCELG,t1 | RCELG,t2 | PriceS&P 500,t | RS&P 500,t3 |
| Jan 31, 2014 | ||||||
| 1. | Feb 28, 2014 | |||||
| 2. | Mar 31, 2014 | |||||
| 3. | Apr 30, 2014 | |||||
| 4. | May 31, 2014 | |||||
| 5. | Jun 30, 2014 | |||||
| 6. | Jul 31, 2014 | |||||
| 7. | Aug 31, 2014 | |||||
| 8. | Sep 30, 2014 | |||||
| 9. | Oct 31, 2014 | |||||
| 10. | Nov 30, 2014 | |||||
| 11. | Dec 31, 2014 | |||||
| 12. | Jan 31, 2015 | |||||
| 13. | Feb 28, 2015 | |||||
| 14. | Mar 31, 2015 | |||||
| 15. | Apr 30, 2015 | |||||
| 16. | May 31, 2015 | |||||
| 17. | Jun 30, 2015 | |||||
| 18. | Jul 31, 2015 | |||||
| 19. | Aug 31, 2015 | |||||
| 20. | Sep 30, 2015 | |||||
| 21. | Oct 31, 2015 | |||||
| 22. | Nov 30, 2015 | |||||
| 23. | Dec 31, 2015 | |||||
| 24. | Jan 31, 2016 | |||||
| 25. | Feb 29, 2016 | |||||
| 26. | Mar 31, 2016 | |||||
| 27. | Apr 30, 2016 | |||||
| 28. | May 31, 2016 | |||||
| 29. | Jun 30, 2016 | |||||
| 30. | Jul 31, 2016 | |||||
| 31. | Aug 31, 2016 | |||||
| 32. | Sep 30, 2016 | |||||
| 33. | Oct 31, 2016 | |||||
| 34. | Nov 30, 2016 | |||||
| 35. | Dec 31, 2016 | |||||
| 36. | Jan 31, 2017 | |||||
| 37. | Feb 28, 2017 | |||||
| 38. | Mar 31, 2017 | |||||
| 39. | Apr 30, 2017 | |||||
| 40. | May 31, 2017 | |||||
| 41. | Jun 30, 2017 | |||||
| 42. | Jul 31, 2017 | |||||
| 43. | Aug 31, 2017 | |||||
| 44. | Sep 30, 2017 | |||||
| 45. | Oct 31, 2017 | |||||
| 46. | Nov 30, 2017 | |||||
| 47. | Dec 31, 2017 | |||||
| 48. | Jan 31, 2018 | |||||
| 49. | Feb 28, 2018 | |||||
| 50. | Mar 31, 2018 | |||||
| 51. | Apr 30, 2018 | |||||
| 52. | May 31, 2018 | |||||
| 53. | Jun 30, 2018 | |||||
| 54. | Jul 31, 2018 | |||||
| 55. | Aug 31, 2018 | |||||
| 56. | Sep 30, 2018 | |||||
| 57. | Oct 31, 2018 | |||||
| 58. | Nov 30, 2018 | |||||
| 59. | Dec 31, 2018 | |||||
| Average (R): | ||||||
| Standard deviation: | ||||||
Show all
1 Data in US$ per share of common stock, adjusted for splits and stock dividends.
2 Rate of return on common stock of CELG during period t
3 Rate of return on S&P 500 (the market portfolio proxy) during period t
Variance and Covariance
Celgene Corp., calculation of variance and covariance of returns
| t | Date | RCELG,t | RS&P 500,t | (RCELG,t–RCELG)2 | (RS&P 500,t–RS&P 500)2 | (RCELG,t–RCELG)×(RS&P 500,t–RS&P 500) |
|---|---|---|---|---|---|---|
| 1. | Feb 28, 2014 | |||||
| 2. | Mar 31, 2014 | |||||
| 3. | Apr 30, 2014 | |||||
| . | . | . | . | . | . | . |
| . | . | . | . | . | . | . |
| . | . | . | . | . | . | . |
| 58. | Nov 30, 2018 | |||||
| 59. | Dec 31, 2018 | |||||
| Total (Σ): | ||||||
| t | Date | RCELG,t | RS&P 500,t | (RCELG,t–RCELG)2 | (RS&P 500,t–RS&P 500)2 | (RCELG,t–RCELG)×(RS&P 500,t–RS&P 500) |
|---|---|---|---|---|---|---|
| 1. | Feb 28, 2014 | |||||
| 2. | Mar 31, 2014 | |||||
| 3. | Apr 30, 2014 | |||||
| 4. | May 31, 2014 | |||||
| 5. | Jun 30, 2014 | |||||
| 6. | Jul 31, 2014 | |||||
| 7. | Aug 31, 2014 | |||||
| 8. | Sep 30, 2014 | |||||
| 9. | Oct 31, 2014 | |||||
| 10. | Nov 30, 2014 | |||||
| 11. | Dec 31, 2014 | |||||
| 12. | Jan 31, 2015 | |||||
| 13. | Feb 28, 2015 | |||||
| 14. | Mar 31, 2015 | |||||
| 15. | Apr 30, 2015 | |||||
| 16. | May 31, 2015 | |||||
| 17. | Jun 30, 2015 | |||||
| 18. | Jul 31, 2015 | |||||
| 19. | Aug 31, 2015 | |||||
| 20. | Sep 30, 2015 | |||||
| 21. | Oct 31, 2015 | |||||
| 22. | Nov 30, 2015 | |||||
| 23. | Dec 31, 2015 | |||||
| 24. | Jan 31, 2016 | |||||
| 25. | Feb 29, 2016 | |||||
| 26. | Mar 31, 2016 | |||||
| 27. | Apr 30, 2016 | |||||
| 28. | May 31, 2016 | |||||
| 29. | Jun 30, 2016 | |||||
| 30. | Jul 31, 2016 | |||||
| 31. | Aug 31, 2016 | |||||
| 32. | Sep 30, 2016 | |||||
| 33. | Oct 31, 2016 | |||||
| 34. | Nov 30, 2016 | |||||
| 35. | Dec 31, 2016 | |||||
| 36. | Jan 31, 2017 | |||||
| 37. | Feb 28, 2017 | |||||
| 38. | Mar 31, 2017 | |||||
| 39. | Apr 30, 2017 | |||||
| 40. | May 31, 2017 | |||||
| 41. | Jun 30, 2017 | |||||
| 42. | Jul 31, 2017 | |||||
| 43. | Aug 31, 2017 | |||||
| 44. | Sep 30, 2017 | |||||
| 45. | Oct 31, 2017 | |||||
| 46. | Nov 30, 2017 | |||||
| 47. | Dec 31, 2017 | |||||
| 48. | Jan 31, 2018 | |||||
| 49. | Feb 28, 2018 | |||||
| 50. | Mar 31, 2018 | |||||
| 51. | Apr 30, 2018 | |||||
| 52. | May 31, 2018 | |||||
| 53. | Jun 30, 2018 | |||||
| 54. | Jul 31, 2018 | |||||
| 55. | Aug 31, 2018 | |||||
| 56. | Sep 30, 2018 | |||||
| 57. | Oct 31, 2018 | |||||
| 58. | Nov 30, 2018 | |||||
| 59. | Dec 31, 2018 | |||||
| Total (Σ): | ||||||
Show all
VarianceCELG = Σ(RCELG,t–RCELG)2 ÷ (59 – 1)
= ÷ (59 – 1)
=
VarianceS&P 500 = Σ(RS&P 500,t–RS&P 500)2 ÷ (59 – 1)
= ÷ (59 – 1)
=
CovarianceCELG, S&P 500 = Σ(RCELG,t–RCELG)×(RS&P 500,t–RS&P 500) ÷ (59 – 1)
= ÷ (59 – 1)
=
Systematic Risk (β) Estimation
| VarianceCELG | |
| VarianceS&P 500 | |
| CovarianceCELG, S&P 500 | |
| Correlation coefficientCELG, S&P 5001 | |
| βCELG2 | |
| αCELG3 |
Calculations
1 Correlation coefficientCELG, S&P 500
= CovarianceCELG, S&P 500 ÷ (Standard deviationCELG × Standard deviationS&P 500)
= ÷ ( × )
=
2 βCELG
= CovarianceCELG, S&P 500 ÷ VarianceS&P 500
= ÷
=
3 αCELG
= AverageCELG – βCELG × AverageS&P 500
= – ×
=
Expected Rate of Return
| Assumptions | ||
| Rate of return on LT Treasury Composite1 | RF | |
| Expected rate of return on market portfolio2 | E(RM) | |
| Systematic risk (β) of Celgene Corp. common stock | βCELG | |
| Expected rate of return on Celgene Corp. common stock3 | E(RCELG) | |
1 Unweighted average of bid yields on all outstanding fixed-coupon U.S. Treasury bonds neither due or callable in less than 10 years (risk-free rate of return proxy).
3 E(RCELG) = RF + βCELG [E(RM) – RF]
= + [ – ]
=